140430 — Catis Balance Sheet
0.000.00%
- KR₩50bn
- KR₩54bn
- KR₩32bn
Annual balance sheet for Catis, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,252 | 8,333 | 2,378 | 7,955 | 9,477 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,454 | 1,895 | 6,054 | 3,706 | 3,253 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,006 | 15,408 | 13,569 | 14,781 | 26,168 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12,179 | 14,275 | 14,931 | 21,289 | 26,603 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 27,871 | 36,298 | 34,734 | 39,252 | 56,197 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11,027 | 17,498 | 13,946 | 8,150 | 21,299 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,473 | 21,981 | 16,761 | 19,123 | 23,185 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12,398 | 14,317 | 17,973 | 20,128 | 33,013 |
Total Liabilities & Shareholders' Equity | 27,871 | 36,298 | 34,734 | 39,252 | 56,197 |
Total Common Shares Outstanding |